Variant report
Variant | nsv1034058 |
---|---|
Chromosome Location | chr8:51907530-51996075 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:171)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF2 | chr8:51934062-51934395 | GM12878 | blood: | n/a | n/a |
2 | BACH1 | chr8:51969835-51969916 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | BACH1 | chr8:51971660-51971674 | H1-hESC | embryonic stem cell: | n/a | n/a |
4 | BATF | chr8:51934115-51934341 | GM12878 | blood: | n/a | chr8:51934250-51934261 |
5 | BATF | chr8:51934082-51934330 | GM12878 | blood: | n/a | chr8:51934250-51934261 |
6 | BCL11A | chr8:51934103-51934327 | GM12878 | blood: | n/a | n/a |
7 | CEBPB | chr8:51995419-51995546 | H1-hESC | embryonic stem cell: | n/a | chr8:51995490-51995501 |
8 | CEBPB | chr8:51995356-51995614 | K562 | blood: | n/a | chr8:51995490-51995501 |
9 | CEBPB | chr8:51943318-51943587 | IMR90 | lung: | n/a | n/a |
10 | CEBPB | chr8:51949260-51949581 | HepG2 | liver: | n/a | n/a |
11 | CEBPB | chr8:51943286-51943588 | HepG2 | liver: | n/a | n/a |
12 | CEBPB | chr8:51995328-51995636 | IMR90 | lung: | n/a | chr8:51995490-51995501 |
13 | CEBPB | chr8:51977057-51977338 | HepG2 | liver: | n/a | chr8:51977198-51977209 |
14 | CEBPB | chr8:51995320-51995560 | HepG2 | liver: | n/a | chr8:51995490-51995501 |
15 | CEBPB | chr8:51950503-51951199 | IMR90 | lung: | n/a | chr8:51950581-51950592 chr8:51950579-51950592 chr8:51950579-51950592 chr8:51950581-51950592 chr8:51951003-51951012 chr8:51950576-51950593 chr8:51951001-51951014 chr8:51951001-51951012 |
16 | CEBPB | chr8:51949273-51949609 | IMR90 | lung: | n/a | n/a |
17 | CEBPB | chr8:51949282-51949619 | A549 | lung: | n/a | n/a |
18 | CEBPB | chr8:51949299-51949587 | MCF-7 | breast: | n/a | n/a |
19 | CEBPB | chr8:51950948-51951182 | HepG2 | liver: | n/a | chr8:51951003-51951012 chr8:51951001-51951014 chr8:51951001-51951012 |
20 | CEBPB | chr8:51977144-51977291 | A549 | lung: | n/a | chr8:51977198-51977209 |
21 | CTCF | chr8:51956514-51956720 | IMR90 | lung: | n/a | n/a |
22 | CTCF | chr8:51956440-51956590 | HBMEC | blood vessel: | n/a | n/a |
23 | CTCF | chr8:51956440-51956590 | HMF | breast: | n/a | n/a |
24 | CTCF | chr8:51956420-51956570 | HRPEpiC | eye: | n/a | n/a |
25 | CTCF | chr8:51913389-51913420 | GM10266 | blood: | n/a | n/a |
26 | CTCF | chr8:51956480-51956630 | HRPEpiC | eye: | n/a | n/a |
27 | CTCF | chr8:51956500-51956650 | NHEK | skin: | n/a | n/a |
28 | CTCF | chr8:51956480-51956630 | HPAF | blood vessel: | n/a | n/a |
29 | CTCF | chr8:51956520-51956670 | HFF | foreskin: | n/a | n/a |
30 | CTCF | chr8:51956460-51956610 | HAc | cerebellar: | n/a | n/a |
31 | CTCF | chr8:51956460-51956610 | AG09309 | skin: | n/a | n/a |
32 | CTCF | chr8:51956506-51956617 | Hela-S3 | cervix: | n/a | n/a |
33 | CTCF | chr8:51960660-51960810 | HAc | cerebellar: | n/a | n/a |
34 | CTCF | chr8:51940220-51940245 | Lung_OC | lung: | n/a | n/a |
35 | CTCF | chr8:51956487-51956603 | Gliobla | brain: | n/a | n/a |
36 | CTCF | chr8:51956520-51956670 | HPAF | blood vessel: | n/a | n/a |
37 | E2F4 | chr8:51956420-51957015 | MCF10A-Er-Src | breast: | n/a | n/a |
38 | E2F4 | chr8:51957637-51957816 | MCF10A-Er-Src | breast: | n/a | n/a |
39 | E2F4 | chr8:51919099-51919441 | MCF10A-Er-Src | breast: | n/a | n/a |
40 | E2F4 | chr8:51937201-51937571 | MCF10A-Er-Src | breast: | n/a | n/a |
41 | E2F4 | chr8:51918023-51918214 | MCF10A-Er-Src | breast: | n/a | n/a |
42 | EBF1 | chr8:51967642-51967682 | GM12878 | blood: | n/a | n/a |
43 | EBF1 | chr8:51932957-51933099 | GM12878 | blood: | n/a | n/a |
44 | EBF1 | chr8:51933670-51934344 | GM12878 | blood: | n/a | n/a |
45 | EP300 | chr8:51934134-51934362 | GM12878 | blood: | n/a | n/a |
46 | EP300 | chr8:51934100-51934384 | GM12878 | blood: | n/a | n/a |
47 | EP300 | chr8:51979118-51979210 | GM12878 | blood: | n/a | n/a |
48 | EP300 | chr8:51933587-51933907 | GM12878 | blood: | n/a | n/a |
49 | EP300 | chr8:51947120-51948021 | SK-N-SH | brain: | n/a | n/a |
50 | EP300 | chr8:51947376-51947680 | SK-N-SH_RA | brain: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000201316 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs537529273 | chr8:51926516-51926517 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs555286238 | chr8:51926518-51926519 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs6998342 | chr8:51926533-51926534 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs550975783 | chr8:51932055-51932056 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs76672651 | chr8:51932056-51932057 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs375606532 | chr8:51932079-51932080 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs368320452 | chr8:51932086-51932087 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs530715102 | chr8:51932112-51932113 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs184748659 | chr8:51932152-51932153 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs189063913 | chr8:51932194-51932195 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs534855579 | chr8:51932200-51932201 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs534943175 | chr8:51933214-51933215 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs553151852 | chr8:51933215-51933216 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs577860825 | chr8:51933361-51933362 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs545189491 | chr8:51933397-51933398 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs563079483 | chr8:51933426-51933427 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs575230199 | chr8:51933428-51933429 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs375024358 | chr8:51933440-51933441 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs184303668 | chr8:51933454-51933455 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs370743862 | chr8:51933544-51933545 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs75458919 | chr8:51933614-51933615 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
22 | rs78092404 | chr8:51933633-51933634 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
23 | rs546870693 | chr8:51933649-51933650 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
24 | rs565177014 | chr8:51933650-51933651 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
25 | rs201106088 | chr8:51933705-51933706 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
26 | rs11782445 | chr8:51933728-51933729 | Enhancers ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs550772507 | chr8:51933775-51933776 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
28 | rs570154771 | chr8:51933793-51933794 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
29 | rs537115508 | chr8:51933802-51933803 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs139878127 | chr8:51933804-51933805 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs117348599 | chr8:51933810-51933811 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs114037509 | chr8:51933835-51933836 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs553290779 | chr8:51933849-51933850 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs370097811 | chr8:51933886-51933887 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs572911232 | chr8:51933895-51933896 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs577903994 | chr8:51933900-51933901 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs558057450 | chr8:51933922-51933923 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs144952910 | chr8:51933953-51933954 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs35689808 | chr8:51933955-51933956 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs188786620 | chr8:51934022-51934023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs575316801 | chr8:51934055-51934056 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs373422927 | chr8:51934070-51934071 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs147952236 | chr8:51934075-51934076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs560943207 | chr8:51934107-51934108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs577143185 | chr8:51934111-51934112 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs141819895 | chr8:51934115-51934116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs181566163 | chr8:51934129-51934130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs371666275 | chr8:51934152-51934153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs73584083 | chr8:51934160-51934161 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs7000380 | chr8:51944616-51944617 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
22q11 deletion syndrome | 20357662 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:51932000-51932200 | Active TSS | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr8:51933200-51933400 | Active TSS | GM12878-XiMat | blood |
3 | chr8:51933400-51933600 | Flanking Active TSS | GM12878-XiMat | blood |
4 | chr8:51933600-51933800 | ZNF genes & repeats | GM12878-XiMat | blood |
5 | chr8:51933600-51934200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
6 | chr8:51933800-51934000 | Flanking Active TSS | GM12878-XiMat | blood |
7 | chr8:51944600-51945000 | Enhancers | Adipose Nuclei | Adipose |
8 | chr8:51947600-51949000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
9 | chr8:51948200-51948800 | Enhancers | NH-A | brain |
10 | chr8:51955800-51957600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
11 | chr8:51956000-51957800 | Enhancers | NH-A | brain |
12 | chr8:51956600-51957800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
13 | chr8:51959000-51959600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
14 | chr8:51966400-51966600 | Enhancers | Esophagus | oesophagus |
15 | chr8:51966400-51968600 | Weak transcription | Gastric | stomach |
16 | chr8:51968600-51968800 | ZNF genes & repeats | Gastric | stomach |
17 | chr8:51968600-51968800 | ZNF genes & repeats | Pancreas | Pancrea |
18 | chr8:51971400-51972400 | Enhancers | Dnd41 | blood |
19 | chr8:51971800-51972200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
20 | chr8:51971800-51972200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
21 | chr8:51972000-51972400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
22 | chr8:51972000-51972400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
23 | chr8:51986000-51986400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
24 | chr8:51990600-51991000 | Active TSS | Primary T helper naive cells from peripheral blood | blood |